
James William Rogers
Examiner (ID: 19129, Phone: (571)272-7838 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1224 |
| Issued Applications | 516 |
| Pending Applications | 132 |
| Abandoned Applications | 593 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15114415
[patent_doc_number] => 20190343840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/525502
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525502 | Risperidone sustained release microsphere composition | Jul 28, 2019 | Issued |
Array
(
[id] => 16267445
[patent_doc_number] => 20200268932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/523303
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523303 | CROSSLINKABLE POLYMER COMPOSITIONS | Jul 25, 2019 | Abandoned |
Array
(
[id] => 17154769
[patent_doc_number] => 20210315820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS
[patent_app_type] => utility
[patent_app_number] => 17/264133
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -134
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264133 | LIPID NANOPARTICLE FORMULATIONS COMPRISING NUCLEIC ACID MIMICS | Jul 24, 2019 | Abandoned |
Array
(
[id] => 17140256
[patent_doc_number] => 20210308267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => REJUVENATION OF CAR T CELL
[patent_app_type] => utility
[patent_app_number] => 17/266509
[patent_app_country] => US
[patent_app_date] => 2019-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266509 | REJUVENATION OF CAR T CELL | Jul 20, 2019 | Abandoned |
Array
(
[id] => 19104617
[patent_doc_number] => 11957690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Chromogenic beta-lactamase substrate
[patent_app_type] => utility
[patent_app_number] => 17/260894
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 11027
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260894 | Chromogenic beta-lactamase substrate | Jul 14, 2019 | Issued |
Array
(
[id] => 15493031
[patent_doc_number] => 20200046704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/511210
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511210 | Sustained release small molecule drug formulation | Jul 14, 2019 | Issued |
Array
(
[id] => 15360805
[patent_doc_number] => 20200016167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Methods for Treating Hyperbilirubinemia with Stannsoporfin
[patent_app_type] => utility
[patent_app_number] => 16/505295
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505295
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505295 | Methods for Treating Hyperbilirubinemia with Stannsoporfin | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15239515
[patent_doc_number] => 20190374543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => Therapeutic Combinations of an Antifolate and a BTK Inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/502545
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502545 | Therapeutic Combinations of an Antifolate and a BTK Inhibitor | Jul 2, 2019 | Abandoned |
Array
(
[id] => 17005305
[patent_doc_number] => 20210236466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/257225
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -169
[patent_words_short_claim] => 1147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257225 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Jul 1, 2019 | Pending |
Array
(
[id] => 16778093
[patent_doc_number] => 20210115171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => RADIOPAQUE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/252552
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252552 | Radiopaque polymers | Jun 25, 2019 | Issued |
Array
(
[id] => 18504693
[patent_doc_number] => 11702498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Radiopaque polymers
[patent_app_type] => utility
[patent_app_number] => 17/252560
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11285
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252560 | Radiopaque polymers | Jun 25, 2019 | Issued |
Array
(
[id] => 17050769
[patent_doc_number] => 20210260203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => POLYPEPT(O)ID-BASED GRAFT COPOLYMERS FOR IN VIVO IMAGING BY TETRAZINE TRANSYCLOOCTENE CLICK CHEMISTRY
[patent_app_type] => utility
[patent_app_number] => 17/256309
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256309 | POLYPEPT(O)ID-BASED GRAFT COPOLYMERS FOR IN VIVO IMAGING BY TETRAZINE TRANSYCLOOCTENE CLICK CHEMISTRY | Jun 25, 2019 | Abandoned |
Array
(
[id] => 17490495
[patent_doc_number] => 11279784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Preparations of meta-iodobenzylguanidine and precursors thereof
[patent_app_type] => utility
[patent_app_number] => 16/437061
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 24479
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16437061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/437061 | Preparations of meta-iodobenzylguanidine and precursors thereof | Jun 10, 2019 | Issued |
Array
(
[id] => 17035217
[patent_doc_number] => 20210252175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => NOVEL COMPOUNDS FOR DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 16/973329
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973329 | NOVEL COMPOUNDS FOR DIAGNOSIS | Jun 6, 2019 | Abandoned |
Array
(
[id] => 16482547
[patent_doc_number] => 20200376147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => SODIUM SACCHARIN HAVING CONJUGATED LIGAND, DERIVATIVES THEREOF AND PROCESS FOR THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/423448
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423448
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423448 | SODIUM SACCHARIN HAVING CONJUGATED LIGAND, DERIVATIVES THEREOF AND PROCESS FOR THE PREPARATION THEREOF | May 27, 2019 | Abandoned |
Array
(
[id] => 16976278
[patent_doc_number] => 20210220515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => VISCOELASTIC AGENT MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/058977
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058977 | VISCOELASTIC AGENT MATERIAL | May 22, 2019 | Abandoned |
Array
(
[id] => 14806391
[patent_doc_number] => 20190269805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => SOLVENT-FREE GADOLINIUM CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/420046
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420046 | SOLVENT-FREE GADOLINIUM CONTRAST AGENTS | May 21, 2019 | Abandoned |
Array
(
[id] => 18133937
[patent_doc_number] => 11559586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Nanoparticles for treatment of choroidal neovascularization and other indications
[patent_app_type] => utility
[patent_app_number] => 17/057630
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 29
[patent_no_of_words] => 15488
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057630 | Nanoparticles for treatment of choroidal neovascularization and other indications | May 20, 2019 | Issued |
Array
(
[id] => 17036611
[patent_doc_number] => 20210253569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => HETEROARYL COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/054015
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054015 | Heteroaryl compounds and uses thereof | May 8, 2019 | Issued |
Array
(
[id] => 18043694
[patent_doc_number] => 11517628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Particles for spatiotemporal release of agents
[patent_app_type] => utility
[patent_app_number] => 17/054119
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 114
[patent_no_of_words] => 31309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054119
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054119 | Particles for spatiotemporal release of agents | May 7, 2019 | Issued |